🧵How long can the Alphabet Agencies and Ivory Towers fight the massive & rising real world data of IVM rapidly stopping &/or preventing COVID surges? It's gonna be a looong walk back from that position man - I would be starting that $%&! walk now (1/5)
2/5 - and Mexico City's Health Dept report of their early treatment program comparing the over 50,000 ppl treated with IVM and the over 70,000 who didn't... Massive 60-75% reduction in need for hospital, helping empty them over 6-12 weeks bit.ly/3liGuOM (2/5)
3/5 - and the Health Ministry of La Pampa, Argentina report on their IVM early Rx program which found 40% less hospitalization and 35% less ICU or death.. insane bit.ly/3zg01o6 (3/5)
4/5 - and the Health Ministry of Misiones, Argentina report on their early Rx program which found a massive 75% reduction in hospitalizations... and an insane 88% reduction in death.. bit.ly/3zg01o6 (4/5)
5/5 - Analysis of Peru's nationwide distribution program
initiated at various times across 25 states of Peru in May 2020, led to a 74% drop in regional excess deaths within a month, with each drop beginning 11 days after each regions program started papers.ssrn.com/sol3/papers.cf…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
1/6 🧵Now lets talk about the #$%! captured medical journals. High impact ones will ONLY publish studies that although they show benefit, don't meet statistical significance. Then they write stuff like "this does not support the use of IVM in COVID" jamanetwork.com/journals/jama/…
2/6 Meanwhile, so much unprecedented crazy shit has happened in journals to positive studies of IVM and other repurporsed drugs it is INSANE. First, know that in the FLCCC's over 100 year academic career (1500 papers), never has any been retracted after passing peer review..
3/6 Here we go: 1) Frontiers in pharmacology (funded by BMGF) retracted our paper... AFTER passing rigorous peer review
1a) They then retract other accepted repurposed drug papers.. editors quit en masse 2) Lancet Respiratory retracted Bryant meta-analysis..AFTER peer review